Nicorandil in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis

doi:10.4330/wjc.v18.i3.116789

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 3

This Article

(37)

(41)

(0)

(729)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Cardiol. Mar 26, 2026; 18(3): 116789
Published online Mar 26, 2026. doi: 10.4330/wjc.v18.i3.116789

Full Size Figure Download Figure

Figure 2 Forest plot for ST-segment resolution following percutaneous coronary intervention. The overall pooled analysis demonstrated a significantly higher rate of complete ST-segment resolution with nicoranadil compared with control. Subgroup analysis stratified by route of administration showed no statistically significant difference. MH: Mantel-Haenszel; CI: Confidence interval; IV: Intravenous; IC: Intracoronary; PO: Per orem.

Citation: Ahmed S, Ahmad E, Ashraf H, Ain HU, Ahmad S, Akram U, Basit J, Hassan IN, Ullah I, Ahmed R, Fonarow GC, Cortese B. Nicorandil in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis. World J Cardiol 2026; 18(3): 116789
URL: https://www.wjgnet.com/1949-8462/full/v18/i3/116789.htm
DOI: https://dx.doi.org/10.4330/wjc.v18.i3.116789

Ahmed S, Ahmad E, Ashraf H, Ain HU, Ahmad S, Akram U, Basit J, Hassan IN, Ullah I, Ahmed R, Fonarow GC, Cortese B. Nicorandil in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis. World J Cardiol 2026; 18(3): 116789 [DOI: 10.4330/wjc.v18.i3.116789]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.